| 2024-05-01 16:02 | CC:TRYP | Tryp Therapeutics Inc | 0.06 | News Release200 | Tryp completes plan of arrangement with Exopharm |
| 2024-04-30 07:47 | CC:TRYP | Tryp Therapeutics Inc | 0.06 | Halt Trading170 | Tryp Therapeutics halted at the open |
| 2024-04-29 10:01 | CC:TRYP | Tryp Therapeutics Inc | 0.06 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-04-29 10:01 | CC:TRYP | Tryp Therapeutics Inc | 0.06 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-04-24 20:17 | CC:TRYP | Tryp Therapeutics Inc | 0.06 | Shares Delisted from CNQ217 | Tryp Therapeutics to be delisted from CSE May 1 |
| 2024-04-24 10:09 | CC:TRYP | Tryp Therapeutics Inc | 0.06 | News Release200 | Tryp target Exopharm receives shareholder OK |
| 2024-03-12 09:22 | CC:TRYP | Tryp Therapeutics Inc | 0.03 | News Release200 | Tryp Therapeutics holders approve Exopharm deal at AGM |
| 2024-03-05 21:33 | CC:TRYP | Tryp Therapeutics Inc | 0.04 | Cease Trade Company Rescinded380 | Tryp Therapeutics reinstated for trading |
| 2024-03-05 13:52 | CC:TRYP | Tryp Therapeutics Inc | 0.04 | Resume Trading385 | Tryp Therapeutics to resume at 11:15 a.m. PT |
| 2024-02-08 16:22 | CC:TRYP | Tryp Therapeutics Inc | 0.04 | News Release200 | Tryp receives interim order for Exopharm deal |
| 2024-02-05 16:54 | CC:TRYP | Tryp Therapeutics Inc | 0.04 | Cease Trade/Suspend Company180 | Tryp Therapeutics suspended by CSE |
| 2024-02-05 12:55 | CC:TRYP | Tryp Therapeutics Inc | 0.04 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-02-05 12:55 | CC:TRYP | Tryp Therapeutics Inc | 0.04 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-02-05 07:50 | CC:TRYP | Tryp Therapeutics Inc | 0.04 | Halt Trading170 | Tryp Therapeutics halted at the open |
| 2024-01-26 09:24 | CC:TRYP | Tryp Therapeutics Inc | 0.045 | News Release200 | Tryp, Exopharm receive two-cent waiver from ASX |
| 2024-01-08 10:47 | CC:TRYP | Tryp Therapeutics Inc | 0.05 | News Release200 | Tryp Therapeutics receives OK for TRP-8803 human trial |
| 2024-01-04 09:13 | CC:TRYP | Tryp Therapeutics Inc | 0.05 | News Release200 | Tryp doses first patient in TRP-8802 phase 2a trial |
| 2023-12-29 18:45 | CC:TRYP | Tryp Therapeutics Inc | 0.04 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-12-29 18:39 | CC:TRYP | Tryp Therapeutics Inc | 0.04 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2023-12-11 09:24 | CC:TRYP | Tryp Therapeutics Inc | 0.045 | News Release200 | Tryp Therapeutics agrees to acquisition by Exopharm |
| 2023-11-20 11:44 | CC:TRYP | Tryp Therapeutics Inc | 0.025 | News Release200 | Tryp Therapeutics closes $3.21M (Australian) financing |
| 2023-11-02 12:58 | CC:TRYP | Tryp Therapeutics Inc | 0.06 | News Release200 | Tryp Therapeutics arranges $3M (Australian) financing |
| 2023-10-11 16:51 | CC:TRYP | Tryp Therapeutics Inc | 0.06 | News Release200 | Tryp closes $175K (Australian) placement to CEO Carroll |
| 2023-08-03 13:43 | CC:TRYP | Tryp Therapeutics Inc | 0.07 | News Release200 | Tryp Therapeutics appoints Carroll as CEO |
| 2023-08-02 13:01 | CC:TRYP | Tryp Therapeutics Inc | 0.07 | News Release200 | Tryp Therapeutics director Tousley dies |
| 2023-07-31 17:43 | CC:TRYP | Tryp Therapeutics Inc | 0.085 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-07-13 09:16 | CC:TRYP | Tryp Therapeutics Inc | 0.08 | News Release200 | Tryp receives FDA OK for phase 2a of IBS trial |
| 2023-05-24 09:51 | CC:TRYP | Tryp Therapeutics Inc | 0.08 | News Release200 | Tryp submits IND application for phase 2a IBS trial |